Childhood-onset systemic lupus erythematosus (cSLE) is a subset of SLE with onset prior to
16–18 years of age. Around 15% of patients with SLE present in childhood; patients with …

This chapter describes the musculoskeletal (MSK) context in children and young people as
an important contributor to the global non-communicable disease burden. Through selected …

In pediatric rheumatology, global health inequity relates to the uneven distribution of
healthcare resources, accessibility, and health outcomes among children with rheumatic …

Cardiovascular involvement in juvenile rheumatic diseases is the primary manifestation in
paediatric vasculitis and a major organ manifestation in paediatric connective tissue …

Abstract Purpose of Review Childhood-onset systemic lupus erythematosus (cSLE) is a
severe and potentially life-threatening chronic autoimmune disease. cSLE is more …

Major health disparities exist among youth with rheumatic diseases. Recent studies in
pediatric rheumatology found that youth from disadvantaged socioeconomic backgrounds …

The global burden of rheumatic disease in the pediatric population is poorly understood but
unrecognized disease greatly impacts the overall morbidity and mortality in this population …

Background There are limited data on neutrophil function in pediatric-onset systemic lupus
erythematosus (pSLE) patients. This study aimed to evaluate phagocytosis and oxidase …

Background Systemic lupus erythematosus (SLE) is a life-threatening, chronic, autoimmune
disease requiring long term subspecialty care due to its complex and chronic nature …

Systemic lupus erythematous (SLE) is an autoimmune disease with a wide range of
cardiovascular complications. The main manifestations include diseases of the coronary …